Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 2176 AL 2190

The role of gamma oscillations in central nervous system diseases: Mechanism and treatment

Guan A, Wang S, Huang A, Qiu C, Li Y, Li X, Wang J, Wang Q, Deng B.

Front Cell Neurosci. 2022 Jul 29;16:962957. doi: 10.3389/fncel.2022.962957. eCollection 2022.

Impact of aging on animal models of Parkinson's disease

Klæstrup IH, Just MK, Holm KL, Alstrup AKO, Romero-Ramos M, Borghammer P, Van Den Berge N.

Front Aging Neurosci. 2022 Jul 28;14:909273. doi: 10.3389/fnagi.2022.909273. eCollection 2022.

Insights into the roles of bacterial infection and antibiotics in Parkinson's disease

Sheng S, Zhao S, Zhang F.

Front Cell Infect Microbiol. 2022 Jul 28;12:939085. doi: 10.3389/fcimb.2022.939085. eCollection 2022.

Complexities of Long-Term Care With Gastro-Jejunal (GJ) Feeding Tubes and Enteral Migration During COVID-19 Pandemic Times: A Case Report

Zafar M, Saddler F, Parvin J, Hennebry E, Pereira R, Austin M.

Cureus. 2022 Aug 11;14(8):e27870. doi: 10.7759/cureus.27870. eCollection 2022 Aug.

Rhythmic auditory stimulation promotes gait recovery in Parkinson's patients: A systematic review and meta-analysis

Ye X, Li L, He R, Jia Y, Poon W.

Front Neurol. 2022 Jul 28;13:940419. doi: 10.3389/fneur.2022.940419. eCollection 2022.

Evaluating Opicapone as Add-on Treatment to Levodopa/DDCI in Patients with Parkinson's Disease

Jost WH.

Neuropsychiatr Dis Treat. 2022 Aug 6;18:1603-1618. doi: 10.2147/NDT.S279362. eCollection 2022.

The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living

Alberts JL, McGrath M, Miller Koop M, Waltz C, Scelina L, Scelina K, Rosenfeldt AB.

J Vis Exp. 2022 Jul 28;(185). doi: 10.3791/63978.

Plasmalogen in the brain: Effects on cognitive functions and behaviors attributable to its properties

Udagawa J, Hino K.

Brain Res Bull. 2022 Oct 1;188:197-202. doi: 10.1016/j.brainresbull.2022.08.008. Epub 2022 Aug 12.

Genome-wide Association and Meta-analysis of Age at Onset in Parkinson Disease: Evidence From the COURAGE-PD Consortium

Grover S, Kumar Sreelatha AA, Pihlstrom L, Domenighetti C, Schulte C, Sugier PE, Radivojkov-Blagojevic M, Lichtner P, Mohamed O, Portugal B, Landoulsi Z, May P, Bobbili D, Edsall C, Bartusch F, Hanussek M, Krüger J, Hernandez DG, Blauwendraat C, Mellick GD, Zimprich A, Pirker W, Tan M, Rogaeva E, Lang A, Koks S, Taba P, Lesage S, Brice A, Corvol JC, Chartier-Harlin MC, Mutez E, Brockmann K, Deutschländer AB, Hadjigeorgiou GM, Dardiotis E, Stefanis L, Simitsi AM, Valente EM, Petrucci S, Straniero L, Zecchinelli A, Pezzoli G, Brighina L, Ferrarese C, Annesi G, Quattrone A, Gagliardi M, Burbulla LF, Matsuo H, Kawamura Y, Hattori N, Nishioka K, Chung SJ, Kim YJ, Pavelka L, van de Warrenburg BPC, Bloem BR, Singleton AB, Aasly J, Toft M, Guedes LC, Ferreira JJ, Bardien S, Carr J, Tolosa E, Ezquerra M, Pastor P, Diez-Fairen M, Wirdefeldt K, Pedersen NL, Ran C, Belin AC, Puschmann A, Hellberg C, Clarke CE, Morrison KE, Krainc D, Farrer MJ, Kruger R, Elbaz A, Gasser T, Sharma M; and the Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson's Disease (COURAGE-PD) Consortium.

Neurology. 2022 Aug 16;99(7):e698-e710. doi: 10.1212/WNL.0000000000200699. Epub 2022 May 26.

Who to Enroll in Parkinson Disease Prevention Trials? The Case for Genetically At-Risk Cohorts

Niotis K, West AB, Saunders-Pullman R.

Neurology. 2022 Aug 16;99(7 Suppl 1):10-18. doi: 10.1212/WNL.0000000000200812.

Path to Parkinson Disease Prevention: Conclusion and Outlook

Berg D, Crotty GF, Keavney JL, Schwarzschild MA, Simuni T, Tanner C.

Neurology. 2022 Aug 16;99(7 Suppl 1):76-83. doi: 10.1212/WNL.0000000000200793.

Neuroprotective Trials in REM Sleep Behavior Disorder: The Way Forward Becomes Clearer

Postuma RB.

Neurology. 2022 Aug 16;99(7 Suppl 1):19-25. doi: 10.1212/WNL.0000000000200235.

Outcome Assessment in Parkinson Disease Prevention Trials: Utility of Clinical and Digital Measures

Mirelman A, Siderowf A, Chahine L.

Neurology. 2022 Aug 16;99(7 Suppl 1):52-60. doi: 10.1212/WNL.0000000000200236.

What to Test in Parkinson Disease Prevention Trials? Repurposed, Low-Risk, and Gene-Targeted Drugs

Crotty GF, Schwarzschild MA.

Neurology. 2022 Aug 16;99(7 Suppl 1):34-41. doi: 10.1212/WNL.0000000000200238.

New-onset Parkinsonism as a Covid-19 infection sequela: A systematic review and meta-analysis

Ali SS, Mumtaz A, Qamar MA, Tebha SS, Parhin A, Butt M, Essar MY.

Ann Med Surg (Lond). 2022 Aug;80:104281. doi: 10.1016/j.amsu.2022.104281. Epub 2022 Aug 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias